Crowdfunded trial tests rapamycin's potential in slowing human ageing
Lifespan.io (LEAF) - 14-Apr-2025A year-long study finds the drug safe at low doses, with early signs of benefit—especially in women
Join the club for FREE to access the whole archive and other member benefits.
Co-Founder AgelessRX - Physician, Entrepreneur, and Innovator
Visit website: http://www.sajadzmd.com/
See also
Online longevity platform that provides access to scientifically-proven therapies to help you live a longer, healthier life
Details last updated 08-Oct-2019
A year-long study finds the drug safe at low doses, with early signs of benefit—especially in women
Safety of rapamycin looks good and lean muscle mass among biomarkers trending towards improvement
We need proactive longevity doctors in the UK to advise on best approaches at an individual level
                                
                                    13-Jan-2021 
                                    
                                
                                                                                
Find out about the history of research of rapamycin in longevity, and this human trial of rapamycin
                                
                                    28-May-2021 
                                    
                                
                                                                                
Find out more about the Participatory Evaluation of Aging with Rapamycin for Longevity Study (FREE)